Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers.
D000374:Aggression / Q000187:drug effects; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001522:Behavior, Animal / Q000187:drug effects*; D002375:Catalepsy / Q000139:chemically induced; D004644:Emotions / Q000187:drug effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005239:Fear / Q000187:drug effects; D005476:Fluphenazine / Q000494:pharmacology; D006120:Grooming / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D009541:Nictitating Membrane / Q000187:drug effects; D010546:Perphenazine / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology* / Q000627:therapeutic use; D011187:Posture / Q000187:drug effects; D011600:Psychopharmacology; D011680:Pupil / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013037:Spatial Behavior / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014828:Vocalization, Animal / Q000187:drug effects; D014851:Wakefulness / Q000187:drug effects
D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D014149:Tranquilizing Agents; D010546:Perphenazine; D005476:Fluphenazine